FiercePharma's sister publication FierceBiotech asked prominent market analysts to weigh in on major biopharma milestones on the near horizon. So Dr. Simos Simeonidis, the senior biotech analyst for Rodman & Renshaw, scanned the radar for key upcoming events. He focuses on five biotech and pharma companies at important crossroads in their development. Their success or failure at this juncture will have a big impact on their future. Article